MREO Mereo BioPharma Group plc
Healthcare · Market cap: $245.5M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $1.3M |
| 2024-Q3 | $0 | $1.8M |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$00 buy days
Sold$3.1M22 sell days
Net insider flow-$3.1Mnet selling · 5 years
Latest trade2024-09-13Hughes-Wilson Alexandra
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2024-09-13 | Sell | Hughes-Wilson Alexandra | Other officer | 100,312 | $4.22 | $423.3K | 2 |
| 2024-09-13 | Sell | Scots-Knight Denise | CEO | 60,046 | $4.22 | $253.4K | 1 |
| 2024-09-13 | Sell | Sermon Charles | General counsel | 20,946 | $4.22 | $88.4K | 1 |
| 2024-09-13 | Sell | Fox Christine Ann | CFO | 19,158 | $4.22 | $80.8K | 1 |
| 2024-09-13 | Sell | Lewicki John A. | Other C-suite | 10,937 | $4.22 | $46.2K | 1 |
| 2024-09-12 | Sell | Hughes-Wilson Alexandra | Other officer | 47,798 | $4.47 | $213.7K | 2 |
| 2024-09-12 | Sell | Scots-Knight Denise | CEO | 28,611 | $4.47 | $127.9K | 1 |
| 2024-09-12 | Sell | Sermon Charles | General counsel | 9,980 | $4.47 | $44.6K | 1 |
| 2024-09-12 | Sell | Fox Christine Ann | CFO | 9,128 | $4.47 | $40.8K | 1 |
| 2024-09-12 | Sell | Lewicki John A. | Other C-suite | 5,212 | $4.47 | $23.3K | 1 |
| 2024-08-22 | Sell | PAKIANATHAN DEEPIKA | Director | 105,244 | $4.43 | $466.2K | 1 |
| 2024-06-26 | Sell | Scots-Knight Denise | CEO | 92,273 | $3.39 | $312.8K | 1 |
| 2024-06-26 | Sell | Sermon Charles | General counsel | 32,187 | $3.39 | $109.1K | 1 |
| 2024-06-26 | Sell | Fox Christine Ann | CFO | 29,439 | $3.39 | $99.8K | 1 |
| 2024-06-26 | Sell | Hughes-Wilson Alexandra | Other officer | 22,968 | $3.39 | $77.9K | 1 |
| 2024-06-26 | Sell | Lewicki John A. | Other C-suite | 16,808 | $3.39 | $57.0K | 1 |
| 2024-06-25 | Sell | Scots-Knight Denise | CEO | 40,712 | $3.69 | $150.2K | 1 |
| 2024-06-25 | Sell | Sermon Charles | General counsel | 14,202 | $3.69 | $52.4K | 1 |
| 2024-06-25 | Sell | Fox Christine Ann | CFO | 12,990 | $3.69 | $47.9K | 1 |
| 2024-06-25 | Sell | Hughes-Wilson Alexandra | Other officer | 10,134 | $3.69 | $37.4K | 1 |
| 2024-06-25 | Sell | Lewicki John A. | Other C-suite | 7,416 | $3.69 | $27.4K | 1 |
| 2024-05-22 | Sell | Hughes-Wilson Alexandra | Other officer | 100,432 | $2.97 | $297.8K | 2 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Hughes-Wilson Alexandra | Other officer | $0 | $1.1M | 2024-09-13 |
| Scots-Knight Denise | CEO | $0 | $844.3K | 2024-09-13 |
| PAKIANATHAN DEEPIKA | Director | $0 | $466.2K | 2024-08-22 |
| Sermon Charles | General counsel | $0 | $294.5K | 2024-09-13 |
| Fox Christine Ann | CFO | $0 | $269.4K | 2024-09-13 |
| Lewicki John A. | Other C-suite | $0 | $153.8K | 2024-09-13 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.